Cancer cells in blood can identify risk of recurrence in breast cancerSeptember 25, 2007Barcelona, Spain: Cancer cells circulating in the blood, or circulating tumour cells (CTCs), are known to be associated with a bad prognosis in women with metastatic breast cancer. Now, for the first time, a group of scientists have shown that they can also detect CTCs before and after chemotherapy treatment and hence may be able to identify those patients likely to have a recurrence of their cancer after such treatment in future. Dr. Julia Jückstock, from the University of Munich, Munich, Germany, told a press conference at the European Cancer Conference (ECCO 14) today (Monday September 24) that the results could help improve the design of trials of chemotherapy in breast cancer, as well as reducing costs to health services. The team, led by Dr. Brigitte Rack, also from Munich, set out to look at the role of CTCs in blood at the first diagnosis of breast cancer and during adjuvant chemotherapy and endocrine treatment. They analysed blood samples from 1,767 node-positive and high-risk node-negative breast cancer patients before the start of their treatment, and compared the results to those obtained from 852 of the same patients after completion of chemotherapy.
"We found that 10 percemt of patients whose blood was sampled before the start of treatment had more than one CTC, and 5 percent of these patients had more than two CTCs in approximately 20 ml of blood," said Dr. Jückstock. The presence of CTCs did not correlate with other prognostic factors such as tumour size, grading, hormonal or Her-2 status, but the scientists did see a significant correlation with the presence of lymph node metastases. Of 24 healthy individuals used as controls, none showed more than one CTC, said the scientists. Among the 852 patients whose blood was analysed post-treatment, 11 percent were CTC positive before the start of treatment, while 7 percent had more than one CTC after completion of chemotherapy. Of those patients who were initially CTC positive, 10 percent remained so and 90 percent had a negative CTC test after chemotherapy. Of those initially CTC negative, 93 percent remained negative, whereas 7 percent had a positive CTC result. The advantage of screening for CTCs is that, unlike other predictive factors, including genetic signatures, it can be carried out after the completion of primary therapy, and, if needed, on other occasions during the duration of disease. Other predictive methods can only be used on diagnosis, and only once, say the scientists. Previous work on the detection of CTCs in bone marrow had also been shown to have predictive value, said Dr. Jückstock. "It is easier to work with bone marrow, because the volume of CTCs is much higher than in blood in the case of a positive status. However, because bone marrow is not easily accessible it is difficult to use this technique on a large scale. It is very much simpler, and more patient-friendly, to take blood samples for analysis. "We think that the persistence of CTCs after chemotherapy treatment is likely to be predictive of the likelihood of recurrence of cancer in these patients," said Dr. Jückstock, "and we will be working to analyse the prognostic value of our findings. If this proves to be the case, it will open the door to a simple way of monitoring the likely outcome of chemotherapy, as well as enabling us to target treatments more precisely. For example, for those patients who have an increased risk of recurrence, we could prolong or alter the chemotherapy regime to give them a better chance of recovery. For those who are likely to respond well to treatment, we could reduce the length of treatment and use less aggressive therapies, thus sparing unpleasant side effects. "We expect to have these results in the next five years," she said, "and if they are as expected, we are optimistic that our research can bring about a real improvement in the way chemotherapy is used in breast cancer patients." Federation of European Cancer Societies Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Dark Energy Wildfires Blood transfusion Retinopathy Tumor Growth Liver Cells Hydrogen Storage Alcohol Dependence Avian influenza Diabetic Retinopathy Anemia Prion Consumers Newborn Screening Monsoon Biofuels Energy Drink Malaria Vaccine Antibiotic Stem cells Melatonin Quantum Physics Abdominal Pain Sustainable Energy Abortion
See More: Science News Tags | |||||||||||||||||||||
|
Related Breast Cancer Current Events and Breast Cancer News Articles Newly appreciated membrane estrogen receptor important therapeutic target for breast cancer New research at Rhode Island Hospital has uncovered the biological effects of a novel membrane estrogen receptor, a finding that has potential implications for hormonal therapy for breast cancer. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. New MRI technique could mean fewer breast biopsies in high-risk women A University of Wisconsin-Madison biomedical engineer and colleagues have developed a method that, applied in MRI scans of the breast, could spare some women with increased breast cancer risk the pain and stress of having to endure a biopsy of a questionable lump or lesion. Researchers pinpoint a new enemy for tumor-suppressor p53 Researchers at The University of Texas M. D. Anderson Cancer Center have identified a protein that marks the tumor suppressor p53 for destruction, providing a potential new avenue for restoring p53 in cancer cells. What should a teenage girl do if she finds a lump in her breast? If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. Study challenges routine use of MRI scans to evaluate breast cancer Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment. A new take on growth factor signaling in tamoxifen resistance Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. Study finds cancer is the second most frequent cause of death in individuals with schizophrenia People with schizophrenia die from cancer four times as often as people in the general population. Green tea may affect prostate cancer progression According to results of a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, men with prostate cancer who consumed the active compounds in green tea demonstrated a significant reduction in serum markers predictive of prostate cancer progression. Novel light-sensitive compounds show promise for cancer therapy Chemists at the University of California, Santa Cruz, have developed novel compounds that show promise for photodynamic cancer therapy, which uses light-activated drugs to kill tumor cells. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||